For example, elevated tissue BCAAs have been observed in patients with HCC previously [28,29], with the latter report also demonstrating a reduction in BCAA catabolic enzymes, in particular BCKDH, the rate-limiting enzyme that commits BCAA catabolites to their oxidative fate. This evidence concerns the gene PPM1K and hepatocellular carcinoma.